Month: July 2021

In this article AXP INTC SAM HON TWTR S3 Studio | Getty Images Check out the companies making headlines in midday trading. Snap — Shares of Snap soared roughly 24% after better-than-expected second-quarter earnings results. The social media company reported strong growth of users, engagement and ads. Twitter — Twitter shares gained 3.4% after reporting its fastest revenue
0 Comments
Cleveland-Cliffs (NYSE:CLF) reported strong second-quarter results on July 22, while the valuation of CLF stock remains extremely low. Also importantly, the macroeconomic and geopolitical pictures are upbeat overall for the steelmaker. Source: Pavel Kapysh / Shutterstock.com Given these points, I recommend that longer-term value investors buy CLF stock. The company saw its stock price rise
0 Comments
There’s no denying that Alibaba (NYSE:BABA) is still an e-commerce giant in China. Yet, at the same time, the current market sentiment isn’t particularly positive towards BABA stock. Source: BigTunaOnline / Shutterstock.com This is typical in the financial markets. A perfectly good company can be a darling one year, and then hated the next year. Informed
0 Comments
Investment bankers are typically the highest-paid workers in the finance industry—high salaries are most prevalent even among younger employees. The starting salary for the typical investment banker exceeds that of most other finance positions, but working in this field has its challenges. Aspiring finance professionals may wish to examine whether a career in investment banking
0 Comments
Mark “Forger” Stucky, after piloting the company’s first successful spaceflight on December 13, 2018. Virgin Galactic Mark “Forger” Stucky, Virgin Galactic‘s flight test director and pilot, is no longer with the space tourism company. “I am now a former Director of Flight Test and former SpaceShipTwo pilot,” Stucky wrote in a post on LinkedIn. He
0 Comments
In the rosiest of scenarios for Ocugen (NASDAQ:OCGN) stock, the Covaxin vaccine for the novel coronavirus will be approved by the FDA only around the second quarter of 2023. And the company appears to be dragging its feet on getting the process started. Source: shutterstock.com/PhotobyTawat Meanwhile, information I recently uncovered suggests that Canada will probably
0 Comments